The Impact of Schistocyte Detection on Mortality and Organ Failure in Patients with Sepsis

View at publisher
Authors: Tomoki Tanaka, Kazunori Fujino, Yasuyuki Tsujita, Yugo Matsumoto, Mitsuhiro Fujino, Hidemitsu Miyatake, Naoto Mizumura, Takayuki Kato, Junji Shimizu, Takuma Kishimoto, Naoto Shiomi
Cited by: 0
References: 1

Abstract

The authors recently discovered incorrect data for procalcitonin. The correct data are shown below. These corrected data in supplemental Table 3 demonstrates that the PCT values were not significantly higher in patients who stayed in ICU for 7 days or more at day 7. PCT was not used in any statistical analyses related to all outcomes in this study, therefore these corrections do not affect the results, interpretation, or conclusions. The authors have thoroughly rechecked all other data and confirmed no further errors. Table 1 Characteristics of two groups of patients at ICU admission - Characteristics Non-schistocyte group (n=289) Schistocyte group (n=41) P value PCT (ng/ml) 5.9 (1.0-26.1) 3.78 (1-25.7) 0.664 Supplemental Table 2 Characteristics of two groups of patients who stayed in ICU for 7 days or more at ICU admission - Characteristics Non-schistocyte group (n=158) Schistocyte group (n=37) P value PCT (ng/ml) 7.9 (1.0-31.2) 4.0 (1.0-25.7) 0.543 Supplemental Table 3 Characteristics of two groups of patients who stayed in ICU for 7 days or more at day 7 - Characteristics Non-schistocyte group (n=158) Schistocyte group (n=37) P value PCT (ng/ml) 1.2 (0.4-4.7) 0.8 (0.4-5.1) 0.724 Data in the tables are represented as the median (first quartile to third quartile). PCT: procalcitonin

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Acute Kidney Injury Research Inflammation biomarkers and pathways

Publication details

Journal / source
Shock
Volume
65
Issue
2
Pages
342–342
Publication date
29 January 2026
Language
EN